S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

IKT Inhibikase Therapeutics Inc

3.27

0.11 (3.48%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Thursday 5 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 5 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 25 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

More Inhibikase Therapeutics Inc News Articles

Impact Fusion (PK)

CyberFuels (PK)

GBT Technologies (PK)

KULR Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions